20
Participants
Start Date
July 31, 2016
Primary Completion Date
August 31, 2017
Study Completion Date
August 31, 2017
Apremilast
"Investigational Product: Apremilast~Doses: Period A:~10mg Per day, day #1, 10mg Twice Per day, day #2 10mg qAM, 20mg qHS day #3 20mg Twice per day, day #4 20mg qAM, 30 mg qHS day #5 30mg Twice per day, day #6~Period B:~30mg Twice per day, day #7 through week #24~Period C:~Week 28 (4 weeks off therapy), for final evaluation Mode of Administration: Oral"
Florida Academic Dermatology Centers, Coral Gables
Florida Academic Dermatology Centers
OTHER